Price
782.5
-0.95%52W Range
Market Cap
₹32,865.51 Cr
Traded: ₹23.69 Cr (0.07%) 0.0x
Free Float: ₹6,185.29 Cr (0.38% of FF traded)
Volume · 60D trend
3.02 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +23.0% | +24.0% | +21.0% | -- | +29.0% | Stable |
| Profit | +25.0% | +4.0% | -9.0% | -- | -32.0% | Decelerating |
| Return | -- | -- | +33.0% | +12.0% | -- | Decelerating |
| ROE | +18.0% | +18.0% | +16.0% | -- | -- | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,180 | 1,075 | 998 | 961 | 872 | 797 | 772 | 777 | 688 | 634 | 606 | 652 | 606 | 576 | 562 | 564 |
| Expenses | 956 | 868 | 799 | 757 | 679 | 599 | 585 | 559 | 509 | 475 | 459 | 475 | 449 | 413 | 411 | 412 |
| Operating Profit | 223 | 206 | 199 | 204 | 193 | 198 | 187 | 218 | 179 | 159 | 147 | 177 | 157 | 163 | 151 | 152 |
| OPM % | 19.0% | 19.0% | 20.0% | 21.0% | 22.0% | 25.0% | 24.0% | 28.0% | 26.0% | 25.0% | 24.0% | 27.0% | 26.0% | 28.0% | 27.0% | 27.0% |
| Other Income | 17 | 1 | 5 | 4 | 7 | 15 | 18 | 5 | 5 | 4 | 3 | 3 | 3 | 5 | 6 | 24 |
| Interest | 83 | 68 | 57 | 45 | 33 | 27 | 26 | 20 | 18 | 16 | 12 | 9 | 9 | 5 | 12 | 8 |
| Depreciation | 101 | 85 | 79 | 66 | 53 | 53 | 45 | 41 | 39 | 46 | 35 | 33 | 32 | 35 | 33 | 31 |
| Profit Before Tax | 57 | 55 | 69 | 97 | 114 | 134 | 135 | 162 | 127 | 100 | 102 | 139 | 119 | 127 | 113 | 137 |
| Tax % | 34.0% | 40.0% | 24.0% | 26.0% | 25.0% | 21.0% | 31.0% | 26.0% | 25.0% | 28.0% | 25.0% | 27.0% | 27.0% | 22.0% | 27.0% | 23.0% |
| Net Profit | 37 | 33 | 52 | 72 | 85 | 106 | 92 | 121 | 95 | 72 | 77 | 101 | 87 | 99 | 82 | 106 |
| Exceptional Items | -- | -11 | 0 | -0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
| EPS (Rs) | 1.0 | 1.1 | 1.3 | 1.7 | 2.0 | 2.5 | 2.2 | 2.7 | 2.2 | 1.6 | 1.8 | 2.3 | 2.0 | 2.3 | 1.9 | 2.4 |
| Sales Growth (YoY) | -- | 34.9% | 29.2% | 23.6% | 26.6% | 25.7% | 27.5% | 19.1% | 13.6% | 10.1% | 7.8% | 15.7% | 22.3% | 54.7% | -- | -- |
| Sales Growth (QoQ) | -- | 7.7% | 3.9% | 10.2% | 9.4% | 3.2% | -0.6% | 12.9% | 8.5% | 4.6% | -7.1% | 7.6% | 5.2% | 2.5% | -0.3% | -- |
| OP Growth (YoY) | 15.5% | 4.0% | 6.4% | -6.4% | 7.8% | 24.5% | 27.2% | 23.2% | 14.0% | -2.5% | -2.6% | 16.4% | -- | -- | -- | -- |
| OP Growth (QoQ) | 8.3% | 3.5% | -2.5% | 5.7% | -2.5% | 5.9% | -14.2% | 21.8% | 12.6% | 8.2% | -16.9% | 12.7% | -3.7% | 7.9% | -0.7% | -- |
| Profit Growth (YoY) | -- | -51.0% | -40.0% | -37.0% | -9.0% | 44.0% | 23.0% | 17.0% | 7.0% | -30.0% | -5.0% | 6.0% | 15.0% | 16.0% | -6.0% | 6.0% |
| EPS Growth (YoY) | -- | -58.3% | -40.1% | -37.7% | -9.3% | 54.9% | 23.3% | 16.5% | 6.9% | -29.6% | -5.3% | -5.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -20.3% | -20.4% | -14.8% | -22.8% | 14.4% | -17.2% | 24.1% | 31.7% | -8.9% | -21.7% | 13.9% | -13.3% | 22.6% | -21.8% | -- |
| OP Margin | -- | 19.2% | 19.9% | 21.2% | 22.1% | 24.8% | 24.2% | 28.1% | 26.0% | 25.1% | 24.3% | 27.1% | 25.9% | 28.3% | 26.9% | 26.9% |
| Net Margin | -- | 3.1% | 5.2% | 7.5% | 9.8% | 13.3% | 11.9% | 15.6% | 13.8% | 11.4% | 12.7% | 15.5% | 14.4% | 17.2% | 14.6% | 18.8% |
| Material Cost % | 20.8% | 21.7% | 19.7% | 20.3% | 21.1% | 21.0% | 20.9% | 20.0% | 20.7% | 21.2% | 20.7% | 21.5% | 21.4% | 21.2% | 22.0% | 22.2% |
| Employee Cost % | 18.0% | 16.7% | 17.7% | 18.2% | 17.3% | 16.8% | 16.5% | 15.3% | 17.2% | 17.1% | 17.2% | 16.2% | 17.1% | 15.9% | 15.5% | 14.9% |
| P/S | 7.80 | 8.82 | 8.40 | 8.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 154.95 | 136.31 | 101.55 | 88.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 14.63 | 15.34 | 13.43 | 13.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50KIMS has entered into Operations and Management agreement with Aurevia Hospitals Private Limited
Allotment of Warrants
Transcript of earnings conference call with investors held on 04 August, 2026
Intimation of receipt of the In-Principal Approval for the issue and allotment of warrants to promoters/promoters group on a preferential basis
Copy of Newspaper Publication towards intimation of notice of 24th Annual General Meeting of the Company.
24th Annual Report for the FY 2025-26
BRSR for the FY 2025-26
24th Annual General Meeting Scheduled to be held on 27th August, 2026
Financial Results for Q1 2026-27
Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018
Voting Results and Scrutinizer Report
Proceedings of the EGM
Corrigendum to Notice of the Extraordinary General Meeting of the Company scheduled to be held on 9 July 2026
Closure of Trading Window for Q1FY27.
Intimation of Approval received from Stock Exchanges for listing of 1,98,67,549 equity shares through QIP.
Outcome For Allotment
outcome
Newspaper Publication - Intimation about EGM
EGM will be held on Thursday, 9th July, 2026 at 4:00 PM
Extraordinary General Meeting of the members of the Company will be held on Thursday 9 July, 2026 at 4:00 PM
Approval of Qualified Institutional Placement
Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March 2026.
Outcome of the meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited (the 'Company') held today i.e., Saturday, 13 June 2026 in terms of the provisions of Regulation ....
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2026 ,inter alia, to consider and approve the proposal ....
JM Financial Centre Stage Conference
one-on-one meeting through calls/video conference
Annual Secretarial Compliance Report for the year ended 31st March, 2026
Transcript of conference call with investors held on 18.05.2026
Intimation of Schedule of analyst or institutional investor meetings
Audio Recording of Conference Call with Investors/ Analysts for Q4 FY26 held on 18.05.2026
Press Release on Q4FY26
Investor Presentation on Q4FY26.
Newspaper Publication on Q4FY26, audited standalone & consolidated financials.
Appointment of Cost Auditors, Appointment of SMP and Re-designation of Director
Outcome of Board Meeting
ResultsQ4FY26
we would be having one-on-one meetings/group meetings through calls/video conference/in person meetings, scheduled to be held from May 18, 2026 to May 22, 2026.
Intimation about a conference call for analysts and investors
Lease Agreement
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the ....
Intimation of entering into Memorandum of Understanding for Strategic Clinical Collaboration
Disclosure of Voting Results of postal Ballot
Certificate u/r 74 (5) of SEBI (DP) Regulations
Intimation u/r 30
the Subsidiary Company has received an order in which the IT Department has set aside the said demand notice and accordingly the amount payable in respect of this matter is 0/-.
Closure for the purpose of consideration of audited financial results (Standalone & Consolidated) for the quarter and year ending 31st March, 2026.
Newspaper Advertisement-Notice of Postal Ballot
Meeting with DAM Capital Hospitals & Diagnostics conference
Postal ballot notice intimation
Meeting with Aberdeen
Credit Ratings
6Concalls
24Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022May 2022
31 May 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021Held by ETFs
14 ETFs hold kims · sorted by weight
Held by Mutual Funds
116 schemes hold kims · sorted by weight